PROCESS FOR PRODUCING AROMATIC COMPOUNDS VIA TREATMENT WITH SUPERCRITICAL WATER
    71.
    发明公开
    PROCESS FOR PRODUCING AROMATIC COMPOUNDS VIA TREATMENT WITH SUPERCRITICAL WATER 有权
    VERFAHREN ZUR HERSTELLUNG AROMATISCHER VERBINDUNGEN DURCH BEHANDLUNG MIT SUPERKRITISCHEM WASSER

    公开(公告)号:EP0989105A1

    公开(公告)日:2000-03-29

    申请号:EP99913604.7

    申请日:1999-04-09

    申请人: SUNTORY LIMITED

    IPC分类号: C07B63/00

    摘要: The present invention provides a process for producing aromatic compounds or polymers thereof from a plant material in a short period of time and by a simple procedure. Concretely, the process treats the plant material with supercritical water or subcritical water to liberate aromatic compounds, which are contained in the plant material, and/or aromatic compounds, which have been generated upon decomposition of components of the plant material, to the outside of the plant material, and isolates the liberated aromatic compounds to produce aromatic compounds or polymers thereof.

    摘要翻译: 本发明提供了一种在短时间内由植物材料制备芳族化合物或其聚合物的方法,并且通过简单的方法。 具体地,该方法用超临界水或亚临界水处理植物材料,以释放植物材料中所含的芳族化合物和/或在植物材料成分分解时产生的芳族化合物, 植物材料,并分离释放的芳族化合物以产生芳族化合物或其聚合物。

    PYRROLOTHIAZINE AND PYRROLOTHIAZEPINE COMPOUNDS HAVING SEROTONIN-2 RECEPTOR ANTAGONISTIC AND ALPHA-1-BLOCKING ACTION
    72.
    发明公开
    PYRROLOTHIAZINE AND PYRROLOTHIAZEPINE COMPOUNDS HAVING SEROTONIN-2 RECEPTOR ANTAGONISTIC AND ALPHA-1-BLOCKING ACTION 审中-公开
    PYRROLOTHIAZIN PYRROLOTHIAZEPINE及其与血清素受体-2- ANATGONISTISCHER和α-1阻断作用的化合物

    公开(公告)号:EP0970089A2

    公开(公告)日:2000-01-12

    申请号:EP98961599.2

    申请日:1998-12-25

    申请人: SUNTORY LIMITED

    IPC分类号: C07D513/04 A61K31/54

    CPC分类号: C07D513/04 C07D207/36

    摘要: A pyrrolesulfonamide compound having formula (I) wherein the ring P represented by (α) is a pyrrole ring having structure (β) or (γ) wherein A represents alkylene, alkenylene or alkynylene; and Y represents a group (δ) in which W represents CH, C= or N; m stands for 0 or 1 when W is CH or N, or m stands for 1 when W is C=; B represents a specific divalent group; E1 and E2 each independently represents H or lower alkyl; and D represents an aromatic hydrocarbon group or heterocyclic group; $(1,3)$ stands for 0 or 1; the dashed line indicates the presence or absence of a bond; and, when the bond is present, Z2 is not present and Z1 represents H but, when the bond is absent, Z1 represents H and Z2 represents OH or Z1 and Z2 are combined together to represent O or a group NOR5, in which R5 represents H, or alkyl, aralkyl or aryl; and R represents H, alkyl, cycloalkyl, cycloalkyl-alkyl or aralkyl. The compound (1) has been improved in potency, selectivity to receptors other than serotonin-2 receptors, toxicity, side effects and/or the like over medicines reported to date and equipped with α1-blocking action and serotonin-2 receptor antagonistic action in combination.

    Process for producing omega-9 highly unsaturated fatty acid and lipid containing the same
    76.
    发明公开
    Process for producing omega-9 highly unsaturated fatty acid and lipid containing the same 失效
    一种用于生产ω-9高度不饱和脂肪酸,和含有该脂质过程

    公开(公告)号:EP0825263A3

    公开(公告)日:1999-09-15

    申请号:EP97306494.2

    申请日:1997-08-26

    申请人: SUNTORY LIMITED

    IPC分类号: C12P7/64

    CPC分类号: C12P7/6427 C12P7/6472

    摘要: The present invention discloses a process for producing lipid containing omega-9 highly unsaturated fatty acid by culturing in a medium a mutant strain obtained by mutation on a microorganism having the ability to produce arachidonic acid belonging to the genus Mortierella and so forth, in which Δ12 desaturation activity is decreased or lost, but at least one of Δ5 desaturation activity, Δ6 desaturation activity and chain length elongation activity is elevated. Moreover, the present invention also discloses a process for producing omega-9 highly unsaturated fatty acid by collecting omega-9 highly unsaturated fatty acid from the culture or lipid described above.

    Mutant staphylococcus aureus V8 proteases
    78.
    发明公开
    Mutant staphylococcus aureus V8 proteases 失效
    金黄色葡萄球菌V8蛋白酶突变体

    公开(公告)号:EP0745669A3

    公开(公告)日:1999-05-26

    申请号:EP96303939.1

    申请日:1996-05-31

    申请人: SUNTORY LIMITED

    IPC分类号: C12N9/00

    摘要: Mutant proteases are obtained with one or more mutation sites in the natural V8 protease protein, and with enzyme activities even in the presence of high urea concentrations. Inactivation of enzyme activity is minimized even in the presence of high concentrations of urea, to thus allow lower amounts of enzyme to be added to urea-containing reaction systems and shorten reaction times. As an additional advantage, the ability to cleave proteins in the presence of high urea concentrations makes it possible to obtain hitherto unobtainable peptide fragments.

    MEDICINAL COMPOSITIONS FOR TREATING CARDIAC DISEASES CAUSED BY CARDIAC HYPERTROPHY
    79.
    发明公开
    MEDICINAL COMPOSITIONS FOR TREATING CARDIAC DISEASES CAUSED BY CARDIAC HYPERTROPHY 失效
    维他命ZUSAMMENSETZUNG ZUR BEHANDLUNG VON HERZKRANKHEITEN VERURSACHT DURCH HERZHYPERTROPHIE

    公开(公告)号:EP0911034A1

    公开(公告)日:1999-04-28

    申请号:EP98901522.7

    申请日:1998-02-05

    申请人: SUNTORY LIMITED

    IPC分类号: A61K38/22 A61K45/00

    CPC分类号: A61K38/2242

    摘要: The present invention provides a pharmaceutical composition for treatment of heart disease based on cardiac hypertrophy, a cause of the onset of heart diseases such as ischemic heart disease and arrhythmia. Consequently, the present invention provides a pharmaceutical composition for treatment of heart disease based on cardiac hypertrophy having for its active ingredient a substance that binds to the NP receptor, GC-A, and is able to accelerate the production of cGMP. Specific examples of active ingredients include natriuretic peptides such as atrial natriuretic peptide and brain natriuretic peptide.

    摘要翻译: 本发明提供了一种用于治疗心脏肥大的心脏病的药物组合物,心脏病发作的原因,例如缺血性心脏病和心律失常。 因此,本发明提供了一种用于治疗基于心脏肥大的心脏病的药物组合物,其具有其活性成分与NP受体结合的物质GC-A,并且能够加速cGMP的产生。 活性成分的具体实例包括利钠肽,例如心房钠尿肽和脑利钠肽。

    Antialopecia agent
    80.
    发明公开
    Antialopecia agent 失效
    Substanz zur Behandlung der Alopezie

    公开(公告)号:EP0796609A3

    公开(公告)日:1999-03-03

    申请号:EP97104606.5

    申请日:1997-03-18

    申请人: SUNTORY LIMITED

    IPC分类号: A61K7/06

    摘要: The present invention provides an antialopecia agent which is a drug for protecting, reducting or preventing alopecia frequently occurring as the side effect of anticancer agents, inflicts neither any pain nor unpleasantness on patients under the treatment with anticancer agents and has a high safety; and foods or beverages containing this antialopecia agent. The antialopecia agent of the present invention is characterized by containing oolong tea extract as the active ingredient.

    摘要翻译: 本发明提供作为抗癌剂的副作用而经常发生的脱发的药物的抗真菌药,对抗癌剂治疗的患者既没有任何疼痛也不令人不快,安全性高; 以及含有该抗真菌药物的食品或饮料。 本发明的抗真菌药物的特征在于含有乌龙茶提取物作为活性成分。